Download View Final Agenda - The Dr. Rath Health Foundation

MEALEY'S Baycol Litigation Conference
June 2-3, 2003, The Ritz-Carlton Hotel, Amelia Island, FL
Conference Chaired by
John M. Restaino, Jr., Esq., Lopez, Hodes, Restaino, Milman & Skikos, Newport Beach, CA
Barry M. Hill, Esq., Hill, Toriseva & Williams PLLC, Wheeling, WV
MONDAY, JUNE 2, 2003
3:00
Afternoon Break
8:00
Registration and Continental Breakfast
3:15
8:45
Introduction and Opening Remarks
John Restaino, Lopez, Hodes, Restaino, Milman & Skikos
Barry Hill, Hill, Toriseva & Williams
9:00
Current State of the Medicine
• Analysis of the current state of the medical
literature
• Significant renal impairment: how to detect it;
causal connection to rhabdo
• Consequences of renal impairment
• Review of the deterioration of kidney function
alleged to be caused by Baycol
• Science of continuing harm
John Restaino, Lopez, Hodes, Restaino, Milman & Skikos
Barry Hill, Hill, Toriseva & Williams
Robert Sufit, M.D., Professor of Neurology,
Northwestern University
Defense Strategies In Handling Pharmaceutical
Cases
• Initial evaluation of pharmaceutical claims
• Strategies for defending drug cases
• Learned intermediary theory
• Examining plaintiffs’ experts
Mark Lynch, Covington & Burling
4:00
Defenses Based On FDA Regulatory Action
• Discussion of the recent intervention of the FDA
in a prescription drug case in defense of the
manufacturer’s prescribing information
Edward Parr, Herman, Mathis, Casey, Kitchens & Gerel
4:45
Case Specific Discovery In Individual Cases
• What kind of information specific to a case should
plaintiffs ask for and receive from defendants?
• Discovery from and about sales representatives
• Samples distributed to prescribing physicians
• Corporate defendants’ specific discovery request
to individual defendants
• Pharmacy defendant discovery
Michael Lynch, Law Offices of Eric H. Weinberg
5:30
Networking Reception with the Faculty
10:15
Morning Break
10:30
Update on the Current Status of Discovery:
State Court Versus the MDL
In state courts
James McHugh, Beasley Firm
In MDL 1431
Charles Zimmerman, Zimmerman Reed
Vance Andrus, Bourdreaux Lemoine & Tonore
11:30
Update on Settlements
In MDL 1431
Charles Zimmerman, Zimmerman Reed
In the Philadelphia and California coordinated litigation
John Restaino, Lopez, Hodes, Restaino, Milman & Skikos
In Texas litigation
Matthew Lundy, Lundy & Davis
12:30
Networking Luncheon
1:30
Trial Report: The Texas Baycol Cases
• Discovery
• Depositions
• Statewide coordination
• Pre-trial motions
• Trial settings
• Corpus Christi trial
• Fort Worth trial
Michael Lynch, Law Offices of Eric H. Weinberg
Gregory Gowan, Watts Law Firm
Matthew Lundy, Lundy & Davis
Dawn Barrios, Barrios Kingsdorf & Casteix
Justin Witkin, Aylstock Witkin & Sasser
2:15
Tuesday, June 3, 2003
8:30
Continental Breakfast
9:00
Judicial Administration of Baycol Litigation
Mary McGovern, Deputy Manager Complex Litigation
Center Court of Common Pleas, Philadelphia County
9:30
Court Mandated Plaintiffs’ Information Forms
In Baycol Mass Litigation
• Philadelphia/California requirements
• MDL 1431 requirements
• Extensions
• Consequences of failing to comply
• Systematic preparation in digital form
Mary Williams, Hill, Toriseva & Williams
10:00
Morning Break
10:15
Ethics In Mass Torts
Howard Erichson, Professor, Seton Hall Law School
11:15
Defending the Treating Physician
• What is the potential liability for the prescribing
physician in Baycol cases?
• How has treating physician liability played out in
the most recent cases?
Russell Thornton, Stinnett Thiebaud & Remington
12:00
The Non-Rhabdo Case: Disease Processes With
or Without Elevated Enzyme Levels
Paul Pennock, Weitz & Luxenberg
12:30
Adjourn
Class Action Status Report
Arnold Levin, Levin, Fishbein, Sedran & Berman